Tafazzin (TAZ) (Middle Region) Peptide
TAZ
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all TAZ products
- TAZ (Tafazzin (TAZ))
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- LHSHFFSLGK CVPVCRGAEF FQAENEGKGV LDTGRHMPGA GKRREKGDGV
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-TAZ Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Tafazzin (TAZ) peptide
TAZ 适用: 人, 小鼠, 大鼠, 犬 宿主: 合成 BP, Imm
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- TAZ (Tafazzin (TAZ))
- 背景
-
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Alias Symbols: TAZ,EFE2,G4.5,
Protein Size: 292 - 基因ID
- 6901
- UniProt
- Q16635
-
You are here:
